Bijoy Hans Limited has formally notified stock exchanges about an upcoming board meeting scheduled for February 13, 2026, to deliberate on the company's third quarter financial performance. The announcement, made in compliance with regulatory requirements, outlines key agenda items and trading restrictions.

Board Meeting Details

The company's Board of Directors will convene on Friday, February 13, 2026, with a focused agenda on financial performance review. The primary objective involves consideration and approval of standalone unaudited financial results for the quarter ended December 31, 2025.

Regulatory Compliance and Trading Window

The announcement fulfills obligations under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review results as recommended by the audit committee, accompanied by the limited review report.

Bijoy Hans Limited has implemented trading window restrictions to ensure compliance with insider trading regulations. The trading window closure, initially communicated on December 23, 2025, became effective from January 1, 2026.

Stock Exchange Communication

The company has formally communicated this development to both Bombay Stock Exchange Limited and The Calcutta Stock Exchange Limited. Bijoy Hans Limited trades under scrip code 524723 on BSE and scrip code 012097 on Calcutta Stock Exchange, with ISIN INE491D01017.

Guinea Agrawal, Company Secretary and Compliance Officer, signed the official communication from Pune, ensuring proper documentation and regulatory adherence for all stakeholders and market participants.

Bijoy Hans Limited announced significant corporate developments following its Board of Directors meeting held on January 31, 2026. The board approved a strategic name change and key director appointment, marking important steps in the company's evolution.

Corporate Name Change Initiative

The board has approved changing the company name from Bijoy Hans Limited to Arvaya Healthtech Limited. This rebranding initiative is intended to better reflect the company's business activities, vision, and long-term objectives. The name change remains subject to obtaining necessary regulatory approvals.

Director Appointment

The board appointed CA Manali Aditya Pandit (DIN 11495478) as a Non-Executive Women Independent Director. Her appointment details are outlined below:

CA Manali Aditya Pandit brings substantial expertise as a Chartered Accountant with nine years of post-qualification experience in internal audit, finance, and business process management. The board confirmed she has no relationships with existing directors and is not related to the promoter or members of the promoter group.

Extraordinary General Meeting Schedule

The board has scheduled an Extraordinary General Meeting (EGM) to seek shareholder approval for the proposed changes. The meeting timeline and key dates are structured as follows:

Meeting Administration

The board appointed M/s CS Chinmay Mohan Lele, Practicing Company Secretary (FCS 12351), as the Scrutinizer to oversee the e-voting process for the EGM. This appointment ensures fair and transparent conduct of the voting procedures.

The board meeting, held at Unit No 408 Third Floor Royal Miraj Arcade, Laxmi Market Miraj Shrikant Chowk, Sangli, Miraj – 416410 Maharashtra, commenced at 03:00 p.m. and concluded at 3:30 p.m. The company has communicated these developments to both the Bombay Stock Exchange and The Calcutta Stock Exchange Limited in compliance with Regulation 30 of SEBI Listing Regulations.